Skip to main navigation
Cue Logo
Skip to Content
Cue Logo
  • Overview
  • News & Events
    • News Releases
    • Events and Presentations
  • Corporate Governance
    • Governance Overview
    • Management Team
    • Board of Directors
    • Committee Composition
  • Financials & Filings
    • SEC Filings
    • Quarterly Results
  • Stock Information
    • Stock Quote
    • Analyst Coverage
  • Resources
    • Investor FAQs
    • Email Alerts
    • Contact Investor Relations

News
Releases

Date Title
Mar 20, 2023
Cue Health Receives FDA Emergency Use Authorization for Molecular Mpox Test
Mar 15, 2023
Cue Health Reports Fourth Quarter and Full-Year 2022 Financial Results
Mar 13, 2023
Cue Health’s New Suite of At-Home Diagnostic Tests and Expansion of Cue Care Puts You in Control of Your Health
Mar 02, 2023
Cue Health Collaborates with Pfizer to Provide People who Test Positive for COVID-19 with Actionable Health Information to Better Inform their Treatment Journey
Mar 01, 2023
Cue Health to Announce Fourth Quarter and Full-Year 2022 Financial Results
Feb 02, 2023
Cue Health to Participate at Upcoming Investor Conferences

Shareholder Tools

Print Page Print Page
Email Alerts Email Alerts
RSS RSS
Contact Contact

This website contains depictions of contemplated future products and future care offerings that are still under development by Cue Health and that have not received regulatory authorization, clearance or approval. Currently, the only products authorized for commercial sale in the United States are Cue Health’s COVID-19 tests, which are currently commercially available in the United States pursuant to two Emergency Use Authorizations from the U.S. Food & Drug Administration.

  • © 2023 Cue Health Inc. All rights reserved. Cue and the Cue logo are registered trademarks of Cue Health Inc.